Anna M. Forsyth

85 Park Road
Grafton, AUK 1023, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Linking human brain functional connectivity to underlying neurotransmission.

Linking human brain functional connectivity to underlying neurotransmission.

Journal: bioRxiv : the preprint server for biology

Published: May 07, 2026

General Anesthesia and Discrete Components of Ketamine Neurophysiology.

General Anesthesia and Discrete Components of Ketamine Neurophysiology.

Journal: JAMA psychiatry

Published: April 08, 2026

Digital Twin Brain simulation and manipulation of a functional brain network underlying mental illness.

Digital Twin Brain simulation and manipulation of a functional brain network underlying mental illness.

Journal: bioRxiv : the preprint server for biology

Published: March 27, 2026

Low-dose naltrexone as an adjunctive treatment for major depressive disorder: findings from a randomized, double-blind, placebo-controlled hybrid parallel-arm study.

Low-dose naltrexone as an adjunctive treatment for major depressive disorder: findings from a randomized, double-blind, placebo-controlled hybrid parallel-arm study.

Journal: Frontiers in pharmacology

Published: December 14, 2025

LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial.

LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: October 02, 2025

What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial.

What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial.

Journal: Therapeutic advances in psychopharmacology

Published: April 02, 2025

Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures.

Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures.

Journal: Neuropharmacology

Published: November 28, 2024

LSD microdosing in major depressive disorder: results from an open-label trial.

LSD microdosing in major depressive disorder: results from an open-label trial.

Journal: Neuropharmacology

Published: November 18, 2024

Local activity alterations in autism spectrum disorder correlate with neurotransmitter properties and ketamine induced brain changes.

Local activity alterations in autism spectrum disorder correlate with neurotransmitter properties and ketamine induced brain changes.

Journal: medRxiv : the preprint server for health sciences

Published: November 06, 2024

Local activity alterations in individuals with autism correlate with neurotransmitter properties and ketamine-induced brain changes.

Local activity alterations in individuals with autism correlate with neurotransmitter properties and ketamine-induced brain changes.

Journal: Nature communications

Published: November 04, 2024

LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.

LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.

Journal: Trials

Published: April 18, 2024

LSD increases sleep duration the night after microdosing.

LSD increases sleep duration the night after microdosing.

Journal: Translational psychiatry

Published: June 27, 2023

Showing 1-12 of 27

Last Updated: 09/26/2026